Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

An immunologic homunculus for type 1 diabetes
Dirk Homann, George S. Eisenbarth
Dirk Homann, George S. Eisenbarth
Published May 1, 2006
Citation Information: J Clin Invest. 2006;116(5):1212-1215. https://doi.org/10.1172/JCI28506.
View: Text | PDF
Commentary Article has an altmetric score of 3

An immunologic homunculus for type 1 diabetes

  • Text
  • PDF
Abstract

Autoimmune diseases such as the diabetes that develops in NOD mice depend on immunologic recognition of specific autoantigens, but recognition can result in a pathogenic or protective T cell response. A study by Du et al. in this issue of the JCI demonstrates that TGF-β signaling by T cells recognizing the insulin peptide B:9–23 is essential for such protection and that this inhibitory cytokine functions in both a paracrine and an autocrine manner (see the related article beginning on page 1360). We propose that the insulin peptide B:9–23 and a conserved TCR motif form an “immunologic homunculus” underlying the relatively common targeting of insulin by T cells that, as demonstrated by the study of Du and coworkers, results in a protective T cell response, or diabetes, as shown by other investigators, for related T cell receptors.

Authors

Dirk Homann, George S. Eisenbarth

×

Total citations by year

Year: 2021 2015 2014 2011 2010 2008 Total
Citations: 1 1 1 1 2 3 9
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (9)

Title and authors Publication Year
A Single L/D-Substitution at Q4 of the mInsA2-10 Epitope Prevents Type 1 Diabetes in Humanized NOD Mice
Zhang M, Wang Y, Li X, Meng G, Chen X, Wang L, Lin Z, Wang L
Frontiers in immunology 2021
Continuum model of T-cell avidity: Understanding autoreactive and regulatory T-cell responses in type 1 diabetes
M Jaberi-Douraki, M Pietropaolo, A Khadra
Journal of Theoretical Biology 2015
Unraveling the contribution of pancreatic beta-cell suicide in autoimmune type 1 diabetes
M Jaberi-Douraki, S Schnell, M Pietropaolo, A Khadra
Journal of Theoretical Biology 2014
Investigating the role of T-cell avidity and killing efficacy in relation to type 1 diabetes prediction
A Khadra, M Pietropaolo, GT Nepom, A Sherman
PloS one 2011
HLA-E Restricted Regulatory CD8+ T Cells Are Involved In Development And Control Of Human Autoimmune Type I Diabetes
Hong Jiang, Stephen M. Canfield, Mary P. Gallagher, Hong Holly Jiang, Yihua Jiang, Zongyu Zheng, Leonard Chess
Journal of Clinical Investigation 2010
Banting Lecture 2009: An Unfinished Journey: Molecular Pathogenesis to Prevention of Type 1A Diabetes
GS Eisenbarth
Diabetes 2010
Insulin as an autoantigen in NOD/human diabetes
L Zhang, M Nakayama, GS Eisenbarth
Current Opinion in Immunology 2008
Conserved T cell receptor alpha-chain induces insulin autoantibodies
M Kobayashi, J Jasinski, E Liu, M Li, D Miao, L Zhang, L Yu, M Nakayama, GS Eisenbarth
Proceedings of the National Academy of Sciences 2008
Primer: Immunity and Autoimmunity
M Pietropaolo, JM Surhigh, PW Nelson, GS Eisenbarth
Diabetes 2008

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
12 readers on Mendeley
See more details